Argyle Capital Management LLC Sells 5,085 Shares of CVS Health Co. (NYSE:CVS)

Argyle Capital Management LLC reduced its position in CVS Health Co. (NYSE:CVS) by 14.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 29,317 shares of the pharmacy operator’s stock after selling 5,085 shares during the quarter. Argyle Capital Management LLC’s holdings in CVS Health were worth $1,316,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health during the 3rd quarter worth about $25,000. Ridgewood Investments LLC lifted its stake in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares during the period. Stonebridge Financial Group LLC acquired a new stake in CVS Health during the fourth quarter valued at approximately $28,000. Legacy Investment Solutions LLC bought a new stake in shares of CVS Health in the 3rd quarter valued at approximately $31,000. Finally, Reston Wealth Management LLC acquired a new position in shares of CVS Health in the 3rd quarter worth approximately $32,000. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on CVS shares. Barclays boosted their price target on CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a research note on Thursday, February 13th. Cantor Fitzgerald raised shares of CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday, February 12th. TD Cowen lifted their price target on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a report on Monday, November 25th. StockNews.com raised shares of CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday, February 13th. Finally, UBS Group cut their target price on shares of CVS Health from $62.00 to $59.00 and set a “neutral” rating for the company in a research note on Tuesday, February 11th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and an average target price of $70.00.

CVS Health Trading Up 1.1 %

Shares of CVS opened at $64.54 on Friday. The stock’s fifty day simple moving average is $53.90 and its 200-day simple moving average is $56.40. The firm has a market capitalization of $81.37 billion, a PE ratio of 17.63, a price-to-earnings-growth ratio of 0.98 and a beta of 0.61. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, research analysts predict that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.12%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is currently 72.68%.

Insider Transactions at CVS Health

In related news, Director Michael F. Mahoney purchased 30,000 shares of the stock in a transaction dated Tuesday, February 18th. The stock was bought at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the purchase, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.24% of the stock is owned by corporate insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.